Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4675-4684
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4675
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4675
$[Label] $[Caption_0]
$[Caption_1]
- Citation: Cruz-Diaz WE, Paitan V, Medina J, Flores R, Haro-Varas J, Mantilla R, Castro-Oliden V. Temozolomide and capecitabine regimen as first-line treatment in advanced gastroenteropancreatic neuroendocrine tumors at a Latin American reference center. World J Gastrointest Oncol 2024; 16(12): 4675-4684
- URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4675.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4675